NCT06634420Phase 3Active not recruiting

HAELO: A Phase 3 Study to Evaluate NTLA-2002 in Participants With Hereditary Angioedema (HAE)

Study sponsor: Intellia Therapeutics

Primary completion is the date data collection ends for the main study measures, not when results are published.

Primary completion2026-02-10Actual
Enrollment · participants80Actual
Source updated2026-10-08Last update listed in the registry record

Changes to this trial

Last 12 months
Filters
Clear filters

· 4 fields changed

Participant count type changed

Before: Estimated. After: Actual.

Enrollment · participant count changed

Before: 60 participants (planned). After: 80 participants (actual).

Completion date type changed

Before: Estimated. After: Actual.

Primary completion date changed

Before: Apr 2026. After: 10 Feb 2026.

Check registry source

Explore older trial changes

Upgrade to Pro to see the full available history for this trial.

Upgrade to Pro Illustrative preview